BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 31895422)

  • 1. Central Visual Field Loss in End-stage Glaucoma.
    Brusini P
    JAMA Ophthalmol; 2020 Feb; 138(2):198-199. PubMed ID: 31895422
    [No Abstract]   [Full Text] [Related]  

  • 2. Visual field changes in primary open-angle glaucoma.
    Chan AK
    Int Ophthalmol Clin; 1979; 19(1):95-125. PubMed ID: 376475
    [No Abstract]   [Full Text] [Related]  

  • 3. [Overall topographic frequency of glaucoma defects. In memory of Erich Seidel (1882-1948)].
    González de La Rosa M; García-Feijoó J
    Arch Soc Esp Oftalmol; 2011 Feb; 86(2):39-41. PubMed ID: 21440828
    [No Abstract]   [Full Text] [Related]  

  • 4. A screening method for temporal visual defects in chronic simple glaucoma.
    Drance SM; Brais P; Fairclough M; Bryett J
    Can J Ophthalmol; 1972 Oct; 7(4):428-9. PubMed ID: 4652815
    [No Abstract]   [Full Text] [Related]  

  • 5. Relationship Between Central Retinal Vessel Trunk Location and Visual Field Loss in Glaucoma.
    Wang M; Wang H; Pasquale LR; Baniasadi N; Shen LQ; Bex PJ; Elze T
    Am J Ophthalmol; 2017 Apr; 176():53-60. PubMed ID: 28088508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lens holder artifact simulating glaucomatous defect in automated perimetry.
    Donahue SP
    Arch Ophthalmol; 1998 Dec; 116(12):1681-3. PubMed ID: 9869806
    [No Abstract]   [Full Text] [Related]  

  • 7. Location of early glaucomatous visual field defects.
    Nicholas SP; Werner EB
    Can J Ophthalmol; 1980 Jul; 15(3):131-3. PubMed ID: 7437940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Central and Peripheral Visual Field Concordance in Glaucoma.
    Odden JL; Mihailovic A; Boland MV; Friedman DS; West SK; Ramulu PY
    Invest Ophthalmol Vis Sci; 2016 May; 57(6):2797-804. PubMed ID: 27214688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Functional glaucoma diagnosis].
    Draeger J
    Ophthalmologe; 2009 Jul; 106(7):646; author reply 646. PubMed ID: 19575204
    [No Abstract]   [Full Text] [Related]  

  • 10. Can DMCO Detect Visual Field Loss in Neurological Patients? A Secondary Validation Study.
    Olsen AS; Steensberg AT; la Cour M; Kjaer TW; Damato B; Pinborg LH; Kolko M
    Ophthalmic Res; 2017; 58(2):85-93. PubMed ID: 28535498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Clues to Predict the Presence of Parafoveal Scotoma on Humphrey 10-2 Visual Field Using a Humphrey 24-2 Visual Field.
    Park HY; Hwang BE; Shin HY; Park CK
    Am J Ophthalmol; 2016 Jan; 161():150-9. PubMed ID: 26476213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a test grid using Eye Movement Perimetry for screening glaucomatous visual field defects.
    Kadavath Meethal NS; Mazumdar D; Asokan R; Panday M; van der Steen J; Vermeer KA; Lemij HG; George RJ; Pel JJM
    Graefes Arch Clin Exp Ophthalmol; 2018 Feb; 256(2):371-379. PubMed ID: 29282563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting conversion to glaucoma using standard automated perimetry and frequency doubling technology.
    Takahashi G; Demirel S; Johnson CA
    Graefes Arch Clin Exp Ophthalmol; 2017 Apr; 255(4):797-803. PubMed ID: 28110356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical experience with circular static perimetry in the glaucoma suspect.
    Pinkerton RM; Reifel C
    Can J Ophthalmol; 1968 Oct; 3(4):318-24. PubMed ID: 5727755
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies in the reproducibility of visual field areas in normal and glaucomatous subjects.
    Drance SM; Berry V; Hughes A
    Can J Ophthalmol; 1966 Jan; 1(1):14-23. PubMed ID: 5914633
    [No Abstract]   [Full Text] [Related]  

  • 16. Detectability of Visual Field Defects in Glaucoma With High-resolution Perimetry.
    Numata T; Matsumoto C; Okuyama S; Tanabe F; Hashimoto S; Nomoto H; Shimomura Y
    J Glaucoma; 2016 Oct; 25(10):847-853. PubMed ID: 27367134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baseline Fourier-Domain Optical Coherence Tomography Structural Risk Factors for Visual Field Progression in the Advanced Imaging for Glaucoma Study.
    Zhang X; Dastiridou A; Francis BA; Tan O; Varma R; Greenfield DS; Schuman JS; Sehi M; Chopra V; Huang D;
    Am J Ophthalmol; 2016 Dec; 172():94-103. PubMed ID: 27651070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Fast Visual Field Loss With Risk of Falling in Patients With Glaucoma.
    Baig S; Diniz-Filho A; Wu Z; Abe RY; Gracitelli CP; Cabezas E; Medeiros FA
    JAMA Ophthalmol; 2016 Aug; 134(8):880-6. PubMed ID: 27280703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Grid for scoring visual fields. II. Perimeter.
    Esterman B
    Arch Ophthalmol; 1968 Apr; 79(4):400-6. PubMed ID: 5694282
    [No Abstract]   [Full Text] [Related]  

  • 20. Stereocampimetry in examination of the central visual fields.
    Hobbs HE
    Trans Ophthalmol Soc U K (1962); 1965; 85():151-5. PubMed ID: 5227177
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.